Chinese Multidisciplinary Expert Consensus on Immune Checkpoint Inhibitor-Based Combination Therapy for Hepatocellular Carcinoma (2023 Edition)

Chinese Multidisciplinary Expert Consensus on Immune Checkpoint Inhibitor-Based Combination Therapy for Hepatocellular Carcinoma (2023 Edition)

Background: Immune checkpoint inhibitor (ICI)-based combination therapy modalities for hepatocellular carcinoma (HCC) have achieved significant efficacy in clinical research and practice and have become the mainstay for the treatment of unresectable HCC. Summary: To better help clinicians use combin...

Full description

Bibliographic Details
Main Authors: Xiufeng Liu, Yinying Lu, Weiping Zhou, Tao Peng, Jie Zhou, Huaqiang Bi, Feng Xia, Xiaoping Chen
Format: Article
Language:English
Published: Karger Publishers 2024-01-01
Series:Liver Cancer
Subjects:
hepatocellular carcinoma
immunotherapy
combination therapy
immune checkpoint inhibitors
multidisciplinary team
consensus
Online Access:https://beta.karger.com/Article/FullText/535496

Internet

https://beta.karger.com/Article/FullText/535496

Similar Items